| Product Code: ETC7582365 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Iran Cannabis Pharmaceutical Market Overview |
3.1 Iran Country Macro Economic Indicators |
3.2 Iran Cannabis Pharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 Iran Cannabis Pharmaceutical Market - Industry Life Cycle |
3.4 Iran Cannabis Pharmaceutical Market - Porter's Five Forces |
3.5 Iran Cannabis Pharmaceutical Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Iran Cannabis Pharmaceutical Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.7 Iran Cannabis Pharmaceutical Market Revenues & Volume Share, By Compound Type, 2021 & 2031F |
3.8 Iran Cannabis Pharmaceutical Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Iran Cannabis Pharmaceutical Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Iran Cannabis Pharmaceutical Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Iran Cannabis Pharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Legalization of medical cannabis in Iran |
4.2.2 Increasing awareness about the potential health benefits of cannabis-based pharmaceuticals |
4.2.3 Growing research and development activities in the cannabis pharmaceutical sector |
4.3 Market Restraints |
4.3.1 Regulatory restrictions and challenges in the cannabis pharmaceutical market in Iran |
4.3.2 Limited availability of high-quality cannabis strains for pharmaceutical use |
4.3.3 Stigma associated with cannabis consumption in traditional societies |
5 Iran Cannabis Pharmaceutical Market Trends |
6 Iran Cannabis Pharmaceutical Market, By Types |
6.1 Iran Cannabis Pharmaceutical Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Iran Cannabis Pharmaceutical Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Iran Cannabis Pharmaceutical Market Revenues & Volume, By Capsules, 2021- 2031F |
6.1.4 Iran Cannabis Pharmaceutical Market Revenues & Volume, By Concentrates, 2021- 2031F |
6.1.5 Iran Cannabis Pharmaceutical Market Revenues & Volume, By Edibles, 2021- 2031F |
6.2 Iran Cannabis Pharmaceutical Market, By Drugs |
6.2.1 Overview and Analysis |
6.2.2 Iran Cannabis Pharmaceutical Market Revenues & Volume, By Epidiolex, 2021- 2031F |
6.2.3 Iran Cannabis Pharmaceutical Market Revenues & Volume, By Marinol, 2021- 2031F |
6.2.4 Iran Cannabis Pharmaceutical Market Revenues & Volume, By Cesamet, 2021- 2031F |
6.2.5 Iran Cannabis Pharmaceutical Market Revenues & Volume, By Sativex, 2021- 2031F |
6.3 Iran Cannabis Pharmaceutical Market, By Compound Type |
6.3.1 Overview and Analysis |
6.3.2 Iran Cannabis Pharmaceutical Market Revenues & Volume, By Tetrahydrocannabinol (THC), 2021- 2031F |
6.3.3 Iran Cannabis Pharmaceutical Market Revenues & Volume, By Cannabidiol (CBD), 2021- 2031F |
6.3.4 Iran Cannabis Pharmaceutical Market Revenues & Volume, By Balanced THC & CBD, 2021- 2031F |
6.4 Iran Cannabis Pharmaceutical Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Iran Cannabis Pharmaceutical Market Revenues & Volume, By Inflammation, 2021- 2031F |
6.4.3 Iran Cannabis Pharmaceutical Market Revenues & Volume, By Chronic Pain, 2021- 2031F |
6.4.4 Iran Cannabis Pharmaceutical Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.4.5 Iran Cannabis Pharmaceutical Market Revenues & Volume, By Sleep Disorders, 2021- 2031F |
6.4.6 Iran Cannabis Pharmaceutical Market Revenues & Volume, By Anorexia, 2021- 2031F |
6.4.7 Iran Cannabis Pharmaceutical Market Revenues & Volume, By Schizophrenia, 2021- 2031F |
6.5 Iran Cannabis Pharmaceutical Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Iran Cannabis Pharmaceutical Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 Iran Cannabis Pharmaceutical Market Revenues & Volume, By Hospital, 2021- 2031F |
6.6 Iran Cannabis Pharmaceutical Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Iran Cannabis Pharmaceutical Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Iran Cannabis Pharmaceutical Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Iran Cannabis Pharmaceutical Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Iran Cannabis Pharmaceutical Market Import-Export Trade Statistics |
7.1 Iran Cannabis Pharmaceutical Market Export to Major Countries |
7.2 Iran Cannabis Pharmaceutical Market Imports from Major Countries |
8 Iran Cannabis Pharmaceutical Market Key Performance Indicators |
8.1 Number of clinical trials conducted on cannabis-based pharmaceuticals in Iran |
8.2 Investment trends in the Iranian cannabis pharmaceutical market |
8.3 Adoption rate of cannabis pharmaceutical products by healthcare professionals in Iran |
9 Iran Cannabis Pharmaceutical Market - Opportunity Assessment |
9.1 Iran Cannabis Pharmaceutical Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Iran Cannabis Pharmaceutical Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.3 Iran Cannabis Pharmaceutical Market Opportunity Assessment, By Compound Type, 2021 & 2031F |
9.4 Iran Cannabis Pharmaceutical Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 Iran Cannabis Pharmaceutical Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Iran Cannabis Pharmaceutical Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Iran Cannabis Pharmaceutical Market - Competitive Landscape |
10.1 Iran Cannabis Pharmaceutical Market Revenue Share, By Companies, 2024 |
10.2 Iran Cannabis Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here